This site is intended for healthcare professionals

Results from phase II ACE-CL-001 trial and Phase III ASCEND trials shows long-term efficacy of Calquence in chronic lymphocytic leukaemia.- AstraZeneca

Read time: 1 mins
Last updated:15th Jun 2020
Published:15th Jun 2020
Condition: CLL/SLL
Type: drug
Register free for full access to